Verrica Pharma signs Israel deal for skin disease treatment YCANTH

Go back to Verrica Pharma signs Israel deal for skin disease treatment YCANTH
(NASDAQ: VRCA) Delayed: 5.26 --0 (-0%)
Previous Close $5.26    52 Week High
Open $5.26    52 Week Low
Day High $5.26    P/E N/A 
Day Low $5.26    EPS
Volume 109